Early-stage venture capital firm CRV has closed a $600 million new fund, which it completely raised during the COVID-19 pandemic.
Subscribe to the Crunchbase Daily
The new fund, CRV XVIII, is the same size as its previous fund although it was oversubscribed, according to a Medium post from CRV. The firm decided to cap the fund at $600 million because it believed that was the right size for CRV’s investing team in the current climate.
“We believe it is essential to continue demonstrating to our entrepreneurs that we are disciplined investors—the same way we rely on them to be great stewards of capital,” the post read. “The venture world is swimming in excess capital. We never want to be the firm that thinks of ‘putting money to work.’ We are helping entrepreneurs build their companies.”
While the world has been turned upside down by the COVID-19 pandemic and most in-person interactions have been on pause for several months, that didn’t have a negative effect on CRV’s fundraising abilities with its limited partners. According to CRV, the fund was raised over 19 days of virtual meetings during the pandemic.
The company focuses mostly on early-stage software investing, but it also has a consumer practice that has backed companies like DoorDash and Patreon. The firm also has a bioengineering investing sector.
The has most recently invested in companies including Glympse Bio, Fauna, Abacus Insights, and Postman,according to Crunchbase. Some of its most notable exits are Twitter and Zendesk’s IPOs, and Amazon’s acquisitions of Ring and PillPack.
Illustration: Li-Anne Dias